UNC Health is a not-for-profit medical system owned by the State of North Carolina and based in Chapel Hill, North Carolina at the University of North Carolina at Chapel Hill. It provides services throughout the Research Triangle and North Carolina.

During the past decade, University of North Carolina Hospitals conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 70 clinical trials were completed, i.e. on average, 73.7% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 31 clinical trials were completed. i.e. 106.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of North Carolina Hospitals" #1 sponsor was "University of North Carolina, Chapel Hill" with 32 trials, followed by "Pfizer" with 14 trials sponsored, "Medical College of Wisconsin" with 11 trials sponsored, "UNC Lineberger Comprehensive Cancer Center" with 8 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 8 trials sponsored. Other sponsors include 121 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina Hospitals" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 20 trials as a collaborator, "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 13 trials as a collaborator, "National Marrow Donor Program" with 13 trials as a collaborator and "Duke University" with 5 trials as a collaborator. Other collaborators include 136 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina Hospitals" are "Cystic Fibrosis" (8 trials), "Acute Myelogenous Leukemia" (4 trials), "Breast Cancer" (4 trials), "HIV Infections" (4 trials) and "Sickle Cell Disease" (4 trials). Many other conditions were trialed in "University of North Carolina Hospitals" in a lesser frequency.

Most popular intervention types in "University of North Carolina Hospitals" are "Drug" (109 trials), "Device" (31 trials), "Other" (28 trials), "Biological" (14 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "IVA" (4 trials), "Fludarabine" (3 trials), "Lenalidomide" (3 trials) and "PF-02341066" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina Hospitals" are 178 trials for "All" genders, 15 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "University of North Carolina Hospitals". undefined are not yet recruiting, 25 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 121 completed trials in University of North Carolina Hospitals, 1 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina Hospitals, 24 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 40 trials that are defined as “Not Applicable".

University of North Carolina Hospitals has several departments that took part in Clinical trials: "UNC Diabetes Care Center" - 13 trials, "North Carolina Memorial Hospital Endoscopy Center" - 2 trials, "UNC Medical Center, Dept. of Rheumatology" - 2 trials